ScholarIQanswers from OpenAlex
Cancer Clinic
InstitutionResearch output, impact & collaborations
Cancer Clinic is a institution indexed in ScholarIQ from OpenAlex.
What is known about Cancer Clinic?
ScholarIQrecord summary
Cancer Clinic is a research organisation in Bryan, US. OpenAlex records 2,709 works and 218,053 citations for it. 942 researchers list it as their most recent affiliation.
How many works does Cancer Clinic have?
ScholarIQindexed works
Cancer Clinic has 2,709 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cancer Clinic have?
ScholarIQcitation count
Cancer Clinic has 218,053 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Cancer Clinic?
ScholarIQresearcher count
Cancer Clinic has 942 researchers in the ScholarIQ index.
What is the average h-index at Cancer Clinic?
ScholarIQavg h-index
Cancer Clinic has an average h-index of 63 in OpenAlex.
What is the ROR of Cancer Clinic?
ScholarIQror
The ROR for Cancer Clinic is on the source record.
What is the OpenAlex record for Cancer Clinic?
ScholarIQopenalex
The OpenAlex for Cancer Clinic is on the source record.
Who are the most-cited researchers behind Cancer Clinic?
ScholarIQtop researchers by citations
What are the most-cited papers on Cancer Clinic?
ScholarIQmost cited works
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli, Rein Willemze, Youn Kim, Robert Knobler, Herschel Zackheim, Madeleine Duvic, Teresa Estrach, Stanford Lamberg, Gary S. Wood, Reinhard Dummer, Annamari Ranki, Günter Burg, Peter Heald, Mark R. Pittelkow, M.G. Bernengo, Wolfram Sterry, L. Laroche, Franz Trautinger, Sean Whittaker
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Paul G. Richardson, Robert Schlossman, Edie Weller, Teru Hideshima, Constantine S. Mitsiades, Faith E. Davies, Richard LeBlanc, Laurence Catley, Deborah Doss, Kathleen Kelly, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca L. Rich, Joan J. Ryoo, Dharminder Chauhan, Kathe Balinski, Jerome B. Zeldis, Kenneth C. Anderson
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen, Sean Whittaker, Youn H. Kim, Madeleine Duvic, H. Miles Prince, Stuart R. Lessin, Gary S. Wood, Rein Willemze, Marie‐France Demierre, Nicola Pimpinelli, Maria Grazia Bernengo, Pablo L. Ortiz‐Romero, M. Bagot, Teresa Estrach, Joan Guitart, Robert Knobler, José Antônio Sanches, Keiji Iwatsuki, Makoto Sugaya, Reinhard Dummer, Mark R. Pittelkow, Richard T. Hoppe, Sareeta Parker, Larisa J. Geskin, Lauren Pinter‐Brown, Michael Girardi, Günter Burg, Annamari Ranki, Maarten H. Vermeer, Sarah McCue Horwitz, Peter Heald, Steven T. Rosen, Lorenzo Cerroni, Brigette Dréno, Eric C. Vonderheid
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, Alain H. Rook, Pierluigi Porcu, Sarah McCue Horwitz, Sean Whittaker, Y. Tokura, Maarten H. Vermeer, Pier Luigi Zinzani, Lubomir Sokol, Stephen Morris, Ellen J. Kim, Pablo L. Ortiz‐Romero, Herbert Eradat, Julia Scarisbrick, Athanasios Tsianakas, Craig A. Elmets, Stéphane Dalle, David C. Fisher, Ahmad Halwani, Brian Poligone, John P. Greer, Maria Teresa Fierro, Amit Khot, Alison J. Moskowitz, Amy Musiek, Andrei R. Shustov, Barbara Pro, Larisa J. Geskin, Karen M. Dwyer, Junji Moriya, Mollie Leoni, Jeffrey S. Humphrey, Stacie Hudgens, Dmitri O. Grebennik, Kensei Tobinai, Madeleine Duvic, Sunil Abhyankar, Oleg E. Akilov, Önder Alpdoğan, M. Beylot‐Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dréno, Reinhard Dummer, Timothy S. Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil J. Korman, Bryone J. Kuss, Zanetta S. Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence A. Mark, Tomomitsu Miyagaki, Javier Muñoz, Jan P. Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem M. William, Kentaro Yonekura
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, Rein Willemze
How much of the research on Cancer Clinic is open access?
ScholarIQopen access share
91%OPEN ACCESS